XML 20 R9.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Cash flows from operating activities:              
Net earnings $ 1,639 $ 29 $ (93) $ 1,879 $ 2,267 $ 3,541  
Adjustments to reconcile net earnings to net cash provided (used) by operating activities:              
Change in receivables and advance premiums         (28) 28  
Capitalization of deferred policy acquisition costs         (796) (767)  
Amortization of deferred policy acquisition costs 218   214   655 638 $ 851
Increase in policy liabilities         (732) (259)  
Change in income tax liabilities         92 (64)  
Net investment (gains) losses (275)   1,408   1,109 (239)  
Other, net         (327) (504)  
Net cash provided (used) by operating activities         2,240 2,374  
Proceeds from investments sold or matured:              
Available-for-sale fixed maturity securities         9,566 4,832  
Equity securities         355 702  
Held-to-maturity fixed maturity securities         2 2  
Commercial mortgage and other loans         1,421 1,482  
Costs of investments acquired:              
Available-for-sale fixed maturity securities         (10,760) (4,589)  
Equity securities         (369) (333)  
Commercial mortgage and other loans         (1,068) (937)  
Other investments, net         (1,109) (2,682)  
Settlement of derivatives, net         13 (92)  
Cash received (pledged or returned) as collateral, net         3,375 2,781  
Other, net         (224) 98  
Net cash provided (used) by investing activities         1,202 1,264  
Cash flows from financing activities:              
Purchases of treasury stock         (2,729) (2,050)  
Proceeds from borrowings         1,039 823  
Principal payments under debt obligations         (84) (194)  
Dividends paid to shareholders         (906) (820)  
Change in investment-type contracts, net         (198) (162)  
Treasury stock reissued         5 21  
Other, net         (12) (20)  
Net cash provided (used) by financing activities         (2,885) (2,402)  
Effect of exchange rate changes on cash and cash equivalents         (18) 70  
Net change in cash and cash equivalents         539 1,306  
Cash and cash equivalents, beginning of period   $ 6,229   $ 4,306 6,229 4,306 4,306
Cash and cash equivalents, end of period $ 6,768   $ 5,612   6,768 5,612 $ 6,229
Supplemental disclosures of cash flow information:              
Income taxes paid         602 805  
Interest paid         133 127  
Noncash interest         25 21  
Noncash real estate acquired in satisfaction of debt         247 380  
Noncash financing activities:              
Lease obligations         25 25  
Associate stock bonus              
Treasury stock issued for:              
Treasury stock issued         17 15  
Shareholder dividend reinvestment              
Treasury stock issued for:              
Treasury stock issued         33 31  
Share-based compensation grants              
Treasury stock issued for:              
Treasury stock issued         $ 7 $ 6